Is rivaroxaban a cost-effective anticoagulation therapy compared with warfarin?

Matthew Hawks, David Moss

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	14-15
Number of pages	2
Journal	Evidence-Based Practice
Volume	20
Issue number	10
State	Published - Oct 2017
Externally published	Yes

Cite this

TY - JOUR

T1 - Is rivaroxaban a cost-effective anticoagulation therapy compared with warfarin?

AU - Hawks, Matthew

AU - Moss, David

PY - 2017/10

Y1 - 2017/10

UR - http://www.scopus.com/inward/record.url?scp=85050731114&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:85050731114

SN - 1095-4120

VL - 20

SP - 14

EP - 15

JO - Evidence-Based Practice

JF - Evidence-Based Practice

IS - 10

ER -